Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Elevated Capital Advisors LLC

Elevated Capital Advisors LLC lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.1% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 1,593 shares of the medical equipment provider’s stock after selling 103 shares during the period. Elevated Capital Advisors LLC’s holdings in Intuitive Surgical were worth $831,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in ISRG. Godsey & Gibb Inc. boosted its stake in Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. acquired a new position in shares of Intuitive Surgical during the 3rd quarter valued at about $33,000. Capital Performance Advisors LLP purchased a new stake in shares of Intuitive Surgical in the third quarter valued at about $38,000. DT Investment Partners LLC increased its position in Intuitive Surgical by 80.0% during the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock worth $40,000 after purchasing an additional 36 shares during the last quarter. Finally, Mark Sheptoff Financial Planning LLC purchased a new position in Intuitive Surgical during the second quarter worth about $37,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other news, SVP Mark Brosius sold 2,128 shares of the business’s stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total value of $1,095,920.00. Following the transaction, the senior vice president now owns 273 shares of the company’s stock, valued at approximately $140,595. The trade was a 88.63 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Brian Edward Miller sold 2,553 shares of the stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total value of $1,314,795.00. Following the sale, the executive vice president now directly owns 7,066 shares of the company’s stock, valued at approximately $3,638,990. This represents a 26.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 48,190 shares of company stock valued at $25,012,927. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Down 1.4 %

Intuitive Surgical stock traded down $7.72 during trading on Monday, reaching $539.75. The stock had a trading volume of 1,387,774 shares, compared to its average volume of 1,350,754. Intuitive Surgical, Inc. has a 52-week low of $355.17 and a 52-week high of $556.23. The stock has a market cap of $192.25 billion, a PE ratio of 86.78, a P/E/G ratio of 5.31 and a beta of 1.39. The business has a 50 day moving average price of $535.93 and a 200 day moving average price of $495.17.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.32. The business had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. On average, equities analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on ISRG shares. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. Mizuho lifted their target price on Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Wells Fargo & Company increased their price target on Intuitive Surgical from $549.00 to $630.00 and gave the stock an “overweight” rating in a report on Wednesday, December 11th. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Robert W. Baird lifted their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $554.17.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.